Indication: Intravenous immunoglobulin (IVIG) is a plasma product administered intravenously, which contains the pooled igG(immunoglobulin (antibody)G). The manufacturing process for IVIG starts from igG extracted from the plasma, then purified through cold ethanol fractionation under low temperature, via low pH virus inactivation method, and nanometer membrane virus filtration, with a content of more than 95% immunoglobulin.

This immunoglobulin is used in the treatment of primary immunoglobulin deficiencies (X chain low immunoglobulin, familiar variable immune deficiency, immunoglobulin G secondary deficiency, etc.), secondary immunoglobulin deficiencies (severe infection, newborn sepsis, etc.), and auto-immune deficiency diseases (such as original thrombocytopenia purpura or Kawasaki disease).

Specifications: 5%: 50ml and 5%: 100ml.